Innovating Works

DC4U

Desconocido
EDUC8: Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity DC4U participó en un H2020: H2020-MSCA-ITN-2019 The development of anti-drug antibodies is the major complication of treatment with biotherapeutics. This is particularly true of patients w...
2019-12-17 - 2024-09-30 | Financiado
GAIT: From symptom relief to disease modifying allergy treatment with Glycan Allergen Immunotherapy DC4U tramitó un H2020: H2020-SMEInst-2016-2017 The annual increase in prevalence of allergy related diseases develops at an alarming pace worldwide. Responsible disease mechanisms are cha...
2017-02-04 - 2017-08-31 | Financiado
GlyCoCan: Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therap... DC4U participó en un H2020: H2020-MSCA-ITN-2015 Colorectal cancer (CRC) is a major worldwide cancer burden with about 1.4 million cases in 2012 and an annual mortality of approximately 700...
2015-08-07 - 2019-08-31 | Financiado
IMMUNOSHAPE: Development of Selective Carbohydrate Immunomodulators Targeting C type Lectin Receptors on Antigen... DC4U participó en un H2020: H2020-MSCA-ITN-2014 IMMUNOSHAPE aims at training a new generation of scientists that will be capable of combining state of the art synthesis and screening techn...
2014-12-12 - 2018-12-31 | Financiado
CARMUSYS: Carbohydrate Multivalent Systems as tools to study Pathogen interaction with DC SIGN DC4U participó en un FP7: The importance of glycosciences in the development of biology and medicine and the central role played by chemistry in this process have rec...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.